CD98 (SLC3A2) as a novel target for receptor-mediated transcytosis at the BBB
Biological drugs over the last decade or so have revolutionised treatment options for a number of diseases. This revolution in treatments...
top of page
BLOG
Contact details
Dr David Dickens
Lecturer in Pharmacology
Pharmacology and Therapeutics
University of Liverpool
Recent Posts
Search By Tags
bottom of page